Kidney Transplant Rejection
Kidney transplant rejection occurs when the immune system attacks the transplanted kidney, which can lead to loss of function. Symptoms may include decreased urine output, swelling, and fever.
MSC Therapy for Kidney Transplant Recipients
We are exploring whether a new therapy using stem cells can improve health outcomes for people who have received a kidney transplant. This study aims to understand its potential benefits in this patient group.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Biopsy-Proven Acute Rejection (BPAR)
Biopsy-Proven Acute Rejection (BPAR) is a type of kidney transplant rejection that is confirmed through a biopsy, indicating that the immune system is actively attacking the transplanted kidney. Symptoms can vary but may include changes in kidney function.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Leids Universitair Medisch Centrum (LUMC)
Nephrology
Leiden, Netherlands
Sponsor: Leids Universitair Medisch Centrum (LUMC)
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.